Immunic, Inc. (IMUX) will implement a 1-for-10 reverse stock split of its outstanding common shares, effective April 27, 2026.
The reverse split aims to help the company meet obligations under a securities purchase agreement signed with institutional and accredited investors on February 12, 2026.
In premarket trading, IMUX shares dropped 4.42% to $0.8602.
Nearly 24 million people in the UK risk overpaying for insurance policies by sticking with auto-renewals without comparing options. Recent…
Veteran Actor Addresses Controversy Surrounding Harry Potter Reboot Academy Award nominee John Lithgow has publicly addressed J.K. Rowling's positions on…
The United States experiences a massive construction surge as it revitalizes its industrial foundation. This effort evolves into a cohesive…
Lantheus Holdings, Inc. (NASDAQ: LNTH) delivered strong first-quarter 2026 results, exceeding analyst expectations for revenue and adjusted earnings per share.…
